Brolucizumab Intravitreal Injections for Wet Age-Related Macular Degeneration: Real-Life Study on a Cohort of Italian Patients

<i>Background and Objectives:</i> To report the real-life Brolucizumab therapeutical outcomes of treatment-naïve and non-treatment-naïve eyes with neovascular age-related macular degeneration (nAMD) and to analyze the incidence of therapy-related adverse events. <i>Materials and Methods:</i> A total...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Carlo Gesualdo, Settimio Rossi, Clemente Maria Iodice, Francesco Guarino, Mariachiara Petrella, Fabiana Anna D’Agostino, Raffaele Perrotta, Francesca Simonelli
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	MDPI AG 2023-06-01
סדרה:	Medicina
נושאים:	age-related macular degeneration anti-vascular endothelial growth factor brolucizumab central retinal thickness exudation intravitreal injection
גישה מקוונת:	https://www.mdpi.com/1648-9144/59/6/1110
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!